EP0458903A4 - Soluble analogs of thrombomodulin - Google Patents

Soluble analogs of thrombomodulin

Info

Publication number
EP0458903A4
EP0458903A4 EP19900904135 EP90904135A EP0458903A4 EP 0458903 A4 EP0458903 A4 EP 0458903A4 EP 19900904135 EP19900904135 EP 19900904135 EP 90904135 A EP90904135 A EP 90904135A EP 0458903 A4 EP0458903 A4 EP 0458903A4
Authority
EP
European Patent Office
Prior art keywords
thrombomodulin
soluble analogs
analogs
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900904135
Other languages
English (en)
Other versions
EP0458903A1 (fr
Inventor
Michael John Morser
Charles Glaser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare Pharmaceuticals Inc
Original Assignee
Codon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codon filed Critical Codon
Publication of EP0458903A1 publication Critical patent/EP0458903A1/fr
Publication of EP0458903A4 publication Critical patent/EP0458903A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/7455Thrombomodulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/90Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/91Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19900904135 1989-02-17 1990-02-16 Soluble analogs of thrombomodulin Withdrawn EP0458903A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US31214189A 1989-02-17 1989-02-17
US312141 1989-02-17
US34537289A 1989-04-28 1989-04-28
US345372 1989-04-28
US40694189A 1989-09-13 1989-09-13
US406941 1989-09-13

Publications (2)

Publication Number Publication Date
EP0458903A1 EP0458903A1 (fr) 1991-12-04
EP0458903A4 true EP0458903A4 (en) 1992-06-17

Family

ID=27405562

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900904135 Withdrawn EP0458903A4 (en) 1989-02-17 1990-02-16 Soluble analogs of thrombomodulin

Country Status (6)

Country Link
EP (1) EP0458903A4 (fr)
JP (1) JPH04505554A (fr)
KR (1) KR920701459A (fr)
AU (1) AU646633B2 (fr)
CA (1) CA2046906A1 (fr)
WO (1) WO1990010081A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DK0544826T3 (da) * 1990-08-15 2002-04-22 Paion Gmbh Overlegne trombomodulinanaloger til farmaceutisk anvendelse
EP0641215B1 (fr) * 1992-02-05 2004-04-21 Paion GmbH Analogues de thrombomoduline resistant a la protease
AU4533093A (en) * 1992-06-10 1994-01-04 Michael John Morser Mutants of the epidermal growth factor domains of human thrombomodulin
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
US5830448A (en) * 1994-06-16 1998-11-03 Genentech, Inc. Compositions and methods for the treatment of tumors
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
CN100412090C (zh) * 2002-05-01 2008-08-20 舍林股份公司 作为抗凝剂的新的靶向组织因子的血栓调节蛋白融合蛋白
CA2609262A1 (fr) 2005-06-03 2006-12-07 Mochida Pharmaceutical Co., Ltd. Proteine fusionnee possedant un anticorps anti-cd14
BR112013002739A2 (pt) * 2010-08-05 2019-09-24 Council Scient Ind Res constructos de proteínas de fusão que possuem propriedades trombolíticas e anticoagulantes
CN119798451B (zh) * 2025-01-06 2025-08-12 印月生物技术(杭州)有限公司 抗人凝血酶调节蛋白的单克隆抗体及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849403A (en) * 1985-05-29 1989-07-18 Pentapharm Ag Protein C activator, methods of preparation and use thereof
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
DK299087D0 (da) * 1987-06-12 1987-06-12 Novo Industri As Proteins and derivatives thereof
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
CA2022713A1 (fr) * 1989-08-11 1991-02-12 Nils U. Bang Derives de thrombomoduline humaine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *
See also references of WO9010081A1 *

Also Published As

Publication number Publication date
KR920701459A (ko) 1992-08-11
WO1990010081A1 (fr) 1990-09-07
AU5191790A (en) 1990-09-26
EP0458903A1 (fr) 1991-12-04
JPH04505554A (ja) 1992-10-01
AU646633B2 (en) 1994-03-03
CA2046906A1 (fr) 1990-08-18

Similar Documents

Publication Publication Date Title
GB8909571D0 (en) Novel cyclopentano-vitamin d analogs
EP0432600A3 (en) Derivatives of 2-iminopyridine
AU105885S (en) Flask
GB8724553D0 (en) Substituted 2-benzylmercapto-imidazoles & analogs
IL96306A0 (en) Preparation of deoxyfluoronucleosides
HU895848D0 (en) Process for the preparation of fluoxethyne analogs
ZA874863B (en) Novel 18-phenyloestrane derivatives
EP0458903A4 (en) Soluble analogs of thrombomodulin
EP0405560A3 (en) Preparation of tertiary-hydrocarbylsilyl compounds
GB8727068D0 (en) Pattern preparation
GB8713987D0 (en) Medicarpin derivatives & analogs
PL286613A1 (en) Method of obraining novel aminopropanel derivatives
JPS6490141A (en) Perfluorobutyl derivative compound
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
YU53490A (en) Derivatives of tetrahydronaphtaline
EP0415320A3 (en) Selective production of threo-epoxy compounds
PL288672A1 (en) Method of obtaining novel derivatives of 2-hydroxy-3-thienyloxypropylamine compounds
ZA897150B (en) Crf analogs
GB2205313B (en) Preparation of trifluoromethyltoluene from halomethylbenzotrifluoride
JPS6490139A (en) Synthesis of cis-9-tricocene
IL95825A0 (en) Production of tetrathiocarbonates
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GR910300027T1 (en) Production of alpha-chloro-alpha-oximino-4-hydroxy-acetophenone
EP0262852A3 (en) Prodrugs of antihypercholoesterolemic compounds
GB8918394D0 (en) Preparation of polyhemiacetals

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910726

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920428

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19940705

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19941116